Panhandle's First State Psychiatric Hospital Breaks Ground
Governor Greg Abbott announced that construction is officially underway on a new state-of-the-art mental health hospital, a modern psychiatric facility in North Texas.
The $159 million project in Amarillo will bring much-needed inpatient mental health services to the 26-county Panhandle area for the first time in state history.
The 75-bed hospital, funded by the Texas Legislature and spearheaded by the Texas Health and Human Services Commission (HHSC), is expected to be finished in 2027. At 164,475 square feet, it is designed to meet modern standards in psychiatric care and will be able to serve adults requiring severe inpatient treatment for psychiatric problems and other ailments.
'Texas is delivering on its promise to expand healthcare to rural communities across our great state,' Abbott said in a June 10 press release announcing the groundbreaking.
'This Panhandle State Hospital – the first state-operated facility in the region – will provide Texans greater access to mental health professionals and high-quality care close to home. I thank the Texas Legislature and the Texas Health and Human Services Commission for their work to increase access to mental healthcare for Texans in every corner of our state,' the governor added.
The new facility will include 'communal activity spaces' and outdoor courtyards to promote recovery and social engagement for psychiatric patients. According to Abbott's office, the hospital's modern design is part of a broader strategy to integrate new evidence-based practices and layouts into mental health facilities.
Cecile Erwin Young, HHSC's executive commissioner, talked about the importance of providing quality care to certain previously underserved communities across Texas.
'Texans are better served when they have access to healthcare closer to home, and that is why state leaders and HHSC have invested in facilities like the Panhandle State Hospital,' Young said.
The Amarillo construction project is part of a sweeping overhaul of the state's mental health infrastructure.
Since 2017, the Abbott administration and Texas lawmakers have allocated over $2.5 billion to modernize and expand the state's psychiatric care system, including renovating, replacing, or constructing hospitals across the state.
The HHSC currently oversees nine different hospitals and one inpatient youth treatment center. These facilities provide 24/7 care for residents struggling with severe mental illness, including those found incompetent to stand trial in the legal system, or deemed a danger to themselves or others.
With rural healthcare access a growing concern across the state, as previously reported on by The Dallas Express, the new hospital will be a big milestone in addressing mental health disparities across Texas.
HHSC's official webpage has construction renderings of the new facility and updates on the project's progress.
'When completed, this hospital will offer hope and healing to some of the most vulnerable people in the Panhandle,' Young added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Panhandle's First State Psychiatric Hospital Breaks Ground
Governor Greg Abbott announced that construction is officially underway on a new state-of-the-art mental health hospital, a modern psychiatric facility in North Texas. The $159 million project in Amarillo will bring much-needed inpatient mental health services to the 26-county Panhandle area for the first time in state history. The 75-bed hospital, funded by the Texas Legislature and spearheaded by the Texas Health and Human Services Commission (HHSC), is expected to be finished in 2027. At 164,475 square feet, it is designed to meet modern standards in psychiatric care and will be able to serve adults requiring severe inpatient treatment for psychiatric problems and other ailments. 'Texas is delivering on its promise to expand healthcare to rural communities across our great state,' Abbott said in a June 10 press release announcing the groundbreaking. 'This Panhandle State Hospital – the first state-operated facility in the region – will provide Texans greater access to mental health professionals and high-quality care close to home. I thank the Texas Legislature and the Texas Health and Human Services Commission for their work to increase access to mental healthcare for Texans in every corner of our state,' the governor added. The new facility will include 'communal activity spaces' and outdoor courtyards to promote recovery and social engagement for psychiatric patients. According to Abbott's office, the hospital's modern design is part of a broader strategy to integrate new evidence-based practices and layouts into mental health facilities. Cecile Erwin Young, HHSC's executive commissioner, talked about the importance of providing quality care to certain previously underserved communities across Texas. 'Texans are better served when they have access to healthcare closer to home, and that is why state leaders and HHSC have invested in facilities like the Panhandle State Hospital,' Young said. The Amarillo construction project is part of a sweeping overhaul of the state's mental health infrastructure. Since 2017, the Abbott administration and Texas lawmakers have allocated over $2.5 billion to modernize and expand the state's psychiatric care system, including renovating, replacing, or constructing hospitals across the state. The HHSC currently oversees nine different hospitals and one inpatient youth treatment center. These facilities provide 24/7 care for residents struggling with severe mental illness, including those found incompetent to stand trial in the legal system, or deemed a danger to themselves or others. With rural healthcare access a growing concern across the state, as previously reported on by The Dallas Express, the new hospital will be a big milestone in addressing mental health disparities across Texas. HHSC's official webpage has construction renderings of the new facility and updates on the project's progress. 'When completed, this hospital will offer hope and healing to some of the most vulnerable people in the Panhandle,' Young added.
Yahoo
a day ago
- Yahoo
In a first for states, Texas might put MAHA warning labels on snack foods
A customer shops for produce at an H-E-B grocery store in Austin, Texas, in February. The Texas legislature recently passed a bill that would require warning labels on foods that contain certain artificial additives and dyes. (Photo by) In a first-of-its-kind effort, the Texas legislature has passed a bill to require warning labels on foods such as Mountain Dew and white bread that contain certain artificial additives and dyes. The measure, now awaiting action by Republican Gov. Greg Abbott, would require a warning label prominently displayed on foods containing any of 44 artificial dyes and additives — a mandate that would apply to popular foods from Doritos and Skittles to Toaster Strudels and breads made with bleached flour. It marks the first time a state, rather than the federal government, has tried to put its own warning labels on food. While the bill passed the Texas House and Senate with bipartisan support, its sponsors are eagerly tying it to U.S. Health and Human Services Secretary Robert F. Kennedy Jr.'s 'Make America Healthy Again' movement. State lawmakers embrace RFK Jr.'s health policies 'This is about the MAHA parents and the crunchy granola parents coming together to say we are sick and tired of being sick and tired,' state Rep. Lacey Hull, who partnered with fellow Republican state Sen. Lois Kolkhorst to sponsor the bill, told legislators before the House voted on May 25. 'I have personally spoken to the White House, who said they are looking to us, to Texas, to get this done, to stand for our children and for our future,' Hull said. Abbott has not yet said whether he will sign the bill. It also includes other statewide health mandates, such as expanding physical activity requirements in public schools and setting new nutrition education requirements for high school and higher education students. But the food warning label has drawn the most attention. The label would read: 'WARNING: This product contains an ingredient that is not recommended for human consumption by the appropriate authority in Australia, Canada, the European Union, or the United Kingdom.' This is about the MAHA parents and the crunchy granola parents coming together to say we are sick and tired of being sick and tired. – Texas Republican state Rep. Lacey Hull Critics of food dyes and additives say they are most often found in low-nutrient, ultra-processed foods that promote unhealthy eating habits and contribute to chronic diseases like obesity and diabetes. Some artificial dyes that are permitted by the U.S. Food and Drug Administration for use in foods are not recommended by its counterparts in other Western countries. European Union regulators require warning labels on some foods containing synthetic dyes, saying they may have an adverse effect on children's activity and attention. In January, the FDA banned the artificial coloring Red No. 3, which is used in many foods and drinks in the U.S. but has been linked to cancer in animals. California became the first state to ban its use in 2023. That bill was sponsored by a Democrat and goes into effect in 2027. But in Texas, the snack industry is pushing back. A coalition of dozens of food industry and business groups — including Walmart, General Mills and Coca-Cola — wrote a letter in opposition to the Texas bill's warning label provision, saying it 'casts an incredibly wide net' and goes too far. 'Problematic' MAHA report minimizes success of lifesaving asthma medicines, doctors say 'Texans deserve honest labeling; but they also deserve public policy that's been studied, vetted, and evaluated for health considerations as well as economic impacts,' the organizations said in a letter circulated around the Texas legislature ahead of the House vote in May. Yet opposition from some of the country's largest food manufacturers may not be enough to halt the MAHA train. The legislation with the labeling requirement joins other Republican-sponsored bills in the Texas legislature and around the country that reflect Kennedy's MAHA agenda, from ending the addition of fluoride to public waters systems to loosening vaccine restrictions. In March, West Virginia became the first state to pass a sweeping ban on synthetic food dyes. At least two dozen other states considered similar food dye bans in this most recent legislative session, according to data from the Environmental Working Group, a research and advocacy group that pushes for removal of chemicals from food and consumer products. At the federal level, the FDA under Kennedy's direction has also asked the food industry to phase out certain synthetic dyes by the end of 2026, though some of the largest companies have said the timeline may not be feasible. Stateline reporter Anna Claire Vollers can be reached at avollers@ SUPPORT: YOU MAKE OUR WORK POSSIBLE
Yahoo
a day ago
- Yahoo
Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions
Tandem Diabetes Care, Inc. recently announced a significant collaboration with Abbott Laboratories to integrate Abbott's upcoming dual glucose-ketone sensor with Tandem's insulin delivery systems. This and other collaborations, such as the agreement with Sequel Med Tech, align with Abbott's strategic focus on enhancing diabetes care. Abbott's shares rose 3% over the last quarter, aligning closely with broader market trends, which advanced 13% over the past year. The company's robust product approvals and partnerships, alongside positive market sentiment, likely reinforced investor confidence in Abbott's growth trajectory amid generally favorable market conditions. You should learn about the 1 possible red flag we've spotted with Abbott Laboratories. Find companies with promising cash flow potential yet trading below their fair value. The recent collaboration between Tandem Diabetes Care, Inc. and Abbott Laboratories to integrate Abbott's dual glucose-ketone sensor has the potential to enhance Abbott's market positioning in diabetes care. This partnership, along with other strategic agreements, could support revenue growth in Abbott's Diabetes Care segment, though challenges such as tariffs and VBP program impacts in China remain. Abbott's five-year total return, including share price and dividends, stands at 63.31%, showcasing strong longer-term performance, despite some earnings forecast pressure. In the past year, Abbott's shares have risen above the US Medical Equipment industry, which saw a return of 8.2%. This outperformance over a shorter time horizon indicates that investor confidence remains buoyant. However, the expectation of declining earnings over the next three years, with a 10.1% decrease per year, highlights forecast challenges. This contrasts with a forecasted revenue growth of 6.9% annually, which is slower than the broader US market growth rate of 8.6% per year. The current share price of US$133.06 reflects a modest 5.2% discount to the consensus analyst price target of US$140.41, suggesting a perception of fair valuation compared to expected earnings growth and projected revenue increases. Insights from our recent valuation report point to the potential undervaluation of Abbott Laboratories shares in the market. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:ABT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
